Study the Safety and Effectiveness of Tadalafil in Men With Problems Getting or Maintaining an Erection When Taken Prior to Desiring an Erection

PHASE3CompletedINTERVENTIONAL
Enrollment

343

Participants

Timeline

Start Date

March 31, 2004

Study Completion Date

November 30, 2004

Conditions
Impotence
Interventions
DRUG

tadalafil

5 mg tadalafil tablet, by mouth, as needed, no more than 1 dose per day, for 12 weeks

DRUG

placebo

placebo tablet taken by mouth, as needed, no more than 1 dose per day, for 12 weeks

DRUG

tadalafil

10 mg tadalafil tablet, by mouth, as needed, no more than 1 dose per day, for 12 weeks

DRUG

tadalafil

20 mg tadalafil tablet, by mouth, as needed, no more than 1 dose per day, for 12 weeks

Trial Locations (1)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon- Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Sapporo

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

ICOS Corporation

INDUSTRY

lead

Eli Lilly and Company

INDUSTRY